Cargando…
Corporate financialization, financing constraints, and innovation efficiency—Empirical evidence based on listed Chinese pharmaceutical companies
The relationship between financialization and innovation has become a common focus of academic attention. This paper analyzes the influence of corporate financialization on innovation efficiency based on balanced panel data of listed Chinese pharmaceutical companies from 2015 to 2020. Also, it exami...
Autores principales: | Zhu, Jialin, Tang, Yaning, Wei, Yanyi, Wang, Su, Chen, Yuwen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10140347/ https://www.ncbi.nlm.nih.gov/pubmed/37124778 http://dx.doi.org/10.3389/fpubh.2023.1085148 |
Ejemplares similares
-
The Impact of the Consistency Evaluation Policy of Generic Drugs on R&D Investment Intensity of Pharmaceutical Companies—An Empirical Study Based on the Difference-in-Differences Model
por: Wei, Yanyi, et al.
Publicado: (2022) -
Corporate social responsibility, financing constraints, and corporate carbon intensity: new evidence from listed Chinese companies
por: Chen, Pengyu
Publicado: (2023) -
Air Pollution and Corporate Green Financial Constraints: Evidence from China’s Listed Companies
por: Shen, Yi, et al.
Publicado: (2022) -
Can digital finance boost SME innovation by easing financing constraints?: Evidence from Chinese GEM-listed companies
por: Yao, Lianying, et al.
Publicado: (2022) -
Can the Market Recognize the Value of the Corporate Governance Mechanism of Chinese Listed Companies?—Empirical Evidence From COVID-19
por: Li, Jianwei, et al.
Publicado: (2022)